Remegen Site #2 — Philadelphia, Pennsylvania

Remegen Site #2 is a clinical research site located in Philadelphia, Pennsylvania, United States 17033.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Remegen Site #2 has participated in 1 clinical trials.

Therapeutic areas: IgA Nephropathy.

Sponsors: RemeGen Co., Ltd..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Remegen Site #2?

Remegen Site #2 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Remegen Site #2 conducted?

Remegen Site #2 has 1 clinical trials on record. Their work covers IgA Nephropathy.

Is Remegen Site #2 accredited by Crixeo Health?

Remegen Site #2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Remegen Site #2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.